Concepedia

Publication | Open Access

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer

DOIFull Paper Access

158

Citations

38

References

2012

Year

Malabika Sen, Sonali Joyce, Mary Panahandeh, Changyou Li, Sufi M. Thomas, Jessica H. Maxwell, Lin Wang, William E. Gooding, Daniel E. Johnson, Jennifer R. Grandis
Clinical Cancer Research

Abstract

These results suggest that STAT3 activation contributes to EGFR inhibitor resistance both in HNSCC and bladder cancer where concomitant targeting of STAT3 may represent an effective treatment strategy.

References

YearCitations

Page 1